Net income
-43.9 million USD
2025-10-01 – 2026-09-30
Market value
$18.26M
91,879,177 shares as of 2026-11-06, at $0.1987 a share (CNTX, IEX close on 2026-11-12) Primary-source evidence
30 filing records in this dataset, filed from 2021-05-27 to 2026-11-10. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-22.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
34400000 USD
91879177 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-43.9 million USD
2025-10-01 – 2026-09-30
-34 million USD
2025-10-01 – 2026-09-30
55.7 thousand USD
2025-10-01 – 2026-09-30
-34 million USD
2025-10-01 – 2026-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-10.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 26.73 million
–
Current period
−USD 36.12 million
–
-36123615 − -26725104 = -9398511 USD
-26725104 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-36123615 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 14.56 million
–
Current period
−USD 26.39 million
–
-26385380 − -14556434 = -11828946 USD
-14556434 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-26385380 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 7,316
–
Current period
USD 33,948
–
33948 − 7316 = 26632 USD
7316 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source33948 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value | Source evidence |
|---|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|
Cash generated by the company’s normal business operations.
| Period | Series | Value | Source evidence |
|---|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2019 2019-01-01 – 2019-12-31 | −USD 6.38 million Exact valueExact value: -6384169 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.84 million Exact valueExact value: -2836098 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | USD 6.64 million Exact valueExact value: 6644465 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.03 million Exact valueExact value: -1034620 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 10.46 million Exact valueExact value: -10456870 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.8 million Exact valueExact value: -8799487 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.8 million Calculation and evidence-8799487 − 0 USD Exact free cash flow: -8799487 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 14.84 million Exact valueExact value: -14835939 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.55 million Exact valueExact value: -13549234 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 36,836 Exact valueExact value: 36836 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.59 million Calculation and evidence-13549234 − 36836 USD Exact free cash flow: -13586070 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 23.96 million Exact valueExact value: -23964211 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.05 million Exact valueExact value: -21047618 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.05 million Calculation and evidence-21047618 − 0 USD Exact free cash flow: -21047618 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 26.73 million Exact valueExact value: -26725104 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.56 million Exact valueExact value: -14556434 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7,316 Exact valueExact value: 7316 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.56 million Calculation and evidence-14556434 − 7316 USD Exact free cash flow: -14563750 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 36.12 million Exact valueExact value: -36123615 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26.39 million Exact valueExact value: -26385380 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 33,948 Exact valueExact value: 33948 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26.42 million Calculation and evidence-26385380 − 33948 USD Exact free cash flow: -26419328 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
30 filings · 1,178 latest values · 1,178 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001842952, 1842952, CNTX, edgar:1842952
Also known as CONTEXT THERAPEUTICS INC., Context Therapeutics Inc., Context Therapeutics LLC